Latest Partnerships News

Zoono Group has secured a five-year exclusive contract with Mpact Operations to apply its antimicrobial technology to corrugated packaging for fresh produce in South Africa and Namibia, aiming to extend shelf-life and reduce food waste.

Larvotto Resources has appointed PYBAR Mining Services to undertake extensive underground development at its Hillgrove Antimony-Gold Project, paving the way for production to commence in 2026.

Growthpoint Properties Australia kicks off FY26 with robust leasing activity, high occupancy rates, and a strategic $24 million industrial acquisition, maintaining its financial guidance and sustainability credentials.

Condor Energy has signed a non-binding MoU with Promigas Perú to jointly explore natural gas supply and distribution opportunities from the Piedra Redonda gas field, aiming to unlock value in northern Peru’s energy market.

PC Gold has entered a $1 million Drill for Equity agreement with DDH1 to advance diamond drilling at its Spring Hill Gold Project, aiming to upgrade resources and push towards production milestones.

Lodestar Minerals has appointed two former heavy rare earths experts from MP Materials and Lynas Rare Earths to spearhead its U.S. downstream magnet and supply chain strategy, following its planned acquisition of the Virgin Mountain project in Arizona.

First Graphene has completed its initial industrial-scale shipment of graphene-enhanced TPU masterbatch to PT Alasmas, marking a key milestone in commercialising advanced materials for durable work boots in Southeast Asia.

Elevra Lithium reports robust Q1 FY26 results with record production and a significant increase in lithium resources, advancing its brownfield expansion and multiple development projects.

Everest Metals has initiated a 2,500m drilling campaign at its Mt Dimer Taipan Gold Project to upgrade and extend its mineral resource ahead of mining operations scheduled for late 2025.

Altech Batteries reveals Sodium-Nickel-Chloride (SNC) batteries achieve an exceptionally low failure rate of 0.6-1.5% over 15+ years in harsh South African conditions, significantly outperforming lithium-ion and lead-acid alternatives.

National Australia Bank reported a modest rise in underlying profit for FY25, driven by robust revenue and volume growth in the second half, alongside continued technology modernization and sustainability progress.

Immuron Limited has secured FDA approval for its IMM-529 Investigational New Drug application, clearing the way for a Phase 2 clinical trial targeting Clostridioides difficile infection. This milestone marks a significant step forward for a novel oral antibody therapy addressing a critical infectious disease with high recurrence rates.